Chemically induced tubal occlusion in the human female using intrauterine instillation of quinacrine.

94 Mora, G., Faundes, A. and Pastore, U. Clinical evaluation of an oral progestin contraceptive, R 2323, 5 mg, administered at weekly intervals. Contraception 10: 145-l 58 t 1974). Tredway, D.R. and Mishell, D.R., Jr. Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels. Contraception 10: 159-l 70 (1974). Johansson, E.D.B. Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta endocr (Kbh) 61: 592-606 (1969). Hotchkiss, J., Atkinson, L.E. and Knobil, E. Time course of serum estrogen and luteinizing hormone (LH) concentrations during the menstrual cycle of the rhesus monkey. Endocrinology 89: 177-l 83 (197 1). Edqvist, L.E. and Johansson, E.D.B. Radioimmunoassay of estrone and estradiol in human and bovine peripheral plasma. Acta endocr (Kbh) 7 1: 7 16-73 1 (1972). Larsson-Cohn, U., Johansson, E.D.B. and Gemzell, C. Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total estrogens. Acta endocr (Kbh) 63: 216-224 (1970). Larsson-Cohn, U., Johansson, E.D.B. and Gemzell, C. Effects of continuous administration of 0.3 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total estrogens. Acta endocr (Kbh) 64: 38-46 (1970). Johansson, E.D.B. and Luukkainen, T. Personal communication. Mora, G. Personal communication.